Amgen Limited has received approval for tarlatamab (Imdyllytra) from the Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of adult patients with small cell lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback